chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.54
Sex: M
Vaccine: RV5, DTAPHEPBIP, FLU3, PNC, RV5
Symptoms: Rotavirus test positive, White blood cell count increased
Clinical narrative: Initial information received on 28 March 2007 from another manufacturer, report number WAES0702USA03484. The initial reporter to this manufacturer has been a health care professional. Information has been received from a pediatrician concerning a 6 month old white male, with a possible history of reflux, who on the morning of 12-FEB-2007 was vaccinated PO with the third 2.0 mL dose of Rotateq (Lot # 656105/1232F). Concomitant vaccines administered on the same day included a third dose in the right anterior thigh of PEDIARIX (Lot# AC21B097AB), a third dose in the left anterior thigh of PREVNAR (B036258B) and a first dose in the right anterior thigh of FLUZONE (Lot# U2285AA). There was no illness at the time of vaccination and no adverse events following prior vaccination. The physician reported that on the night of 15-FEB-2007, the patient developed hematochezia and was taken to the Emergency Room (ER). The patient's stool tested positive for rotavirus (type not known). The patient was subsequently released from the ER. On 16-FEB-2007, the patient was seen by the pediatrician. No further sequelae was noted as the patient was considered to be fully recovered. Follow-up information from a pediatrician via medical records indicated that on 15-FEB-2007 the patient reported to the emergency room via a private vehicle. There, the patient's mother stated that the child had three episodes of diarrhea which all contained a slight bit of which looked to be blood. The patient's mother contacted her pediatrician's office and the answering service directed her to come to the emergency room stating that it could have possibly been a reaction to the immunizations that she just received, which was Rotateq, which she just had her third dose on 12-FEB-2007. The patient had been fine all week, however on that day she had a little bit of mucous and blood in her stool, a low grade fever, and was also acting quite fussy. The patient started with a small cough and started with a rash since she had been there. During the course in the emergency room, a positive heme occult from the patient's diaper was obtained that was presented to the mother that did show some tiny specks of blood. The patient was positive rotavirus via a rectal swab, and had mild diarrhea. The patient was well after this. There was no severe belly pain or intussusception. The patient was seen in the pediatrician's office for follow up on 16-FEB-2007, and had recovered.  Upon internal review, hematochezia was determined to be an other important medical event. Additional information is not expected.
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Barium double contrast, Intussusception
Clinical narrative: Information has been received from FDA through the CDC concerning a female with congenital Dacryostenosis who on 25-JAN-2007, at 1130, was vaccinated PO with the first dose of Rotateq (Lot #656103/1166F). Concomitant vaccinations administered on the same day and time included the first IM dose in the left leg of DAPTACEL (Lot #C2521AA), the first dose IM in the left leg of Comvax (Lot #654993/1158F), the first IM dose in the right leg of PREVNAR (lot #B08670F) and the first IM dose in the right leg of IPOL (Lot #Z0324). There was no illness at the time of vaccination. Other concomitant drug therapy included POLYTRIM. On 10-MAR-2007, the patient was taken to the Emergency Room (ER). An air-contrast barium enema was positive for intussusception. A diagnosis of intussusception was made by the hospital. In March 2007, the patient recovered. Upon internal review, intussusception was determined to be an other important medical event. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met requirements of the Center for Biologics Evaluation and Research (CBER) and was released by the regulatory agency. No further information is available.
Sex: F
Vaccine: DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5, DTAP, HBHEPB, IPV, PNC, RV5
Symptoms: Barium double contrast, Emergency care examination abnormal, Intussusception
Clinical narrative: Information has been received from FDA through the CDC concerning a female with congenital Dacryostenosis who on 25-JAN-2007, at 1130, was vaccinated PO with the first dose of Rotateq (Lot #656103/1166F). Concomitant vaccinations administered on the same day and time included the first IM dose in the left leg of DAPTACEL (Lot #C2521AA), the first dose IM in the left leg of Comvax (Lot #654993/1158F), the first IM dose in the right leg of PREVNAR (lot #B08670F) and the first IM dose in the right leg of IPOL (Lot #Z0324). There was no illness at the time of vaccination. Other concomitant drug therapy included POLYTRIM. On 10-MAR-2007, the patient was taken to the Emergency Room (ER). An air-contrast barium enema was positive for intussusception. A diagnosis of intussusception was made by the hospital. In March 2007, the patient recovered. Upon internal review, intussusception was determined to be an other important medical event. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met requirements of the Center for Biologics Evaluation and Research (CBER) and was released by the regulatory agency. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Abortion spontaneous, Drug exposure during pregnancy
Clinical narrative: Information has been received through the pregnancy registry from a physician concerning a female teenager who was vaccinated with a first dose of Gardasil without the knowledge that she was pregnant. It was found out that the patient was pregnant after the administration of the vaccine. Later the patient had a miscarriage. As per the reporter, the miscarriage happened "last month or so." Medical attention was sought. The patient was recovering. Upon internal review, miscarriage was considered to be an other important medical event. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Abdominal pain, Laboratory test normal
Clinical narrative: Information has been received from a pharmacist (PharmD) concerning a female (age unknown) patient who on 26-MAR-2007 was vaccinated with a dose of Gardasil which was thought by the reporter to be her initial dose. Subsequently, on an unspecified date, the patient experienced generalized abdominal pain and was hospitalized on 29-MAR-2007 to rule out appendicitis. The pharmacist stated that all of the patient's test have come back normal but could not identify specifically what tests or labs were performed. It was noted that the patient was treated with IV fluids and pain medication as needed. At the time of this report, the patient had not recovered. No product quality complaint was involved. The reporter considered generalized abdominal pain to be an other important medical event. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Computerised tomogram, Convulsion, Emergency care examination, Fatigue, Laboratory test
Clinical narrative: Information has been received from a physician concerning a 24 year old white female with no pertinent medical history who on 13-MAR-2007, at 08:30, was vaccinated, into the right deltoid, with a first dose of GARDASIL (lot #657006/0188U). Concomitant therapy included ZYRTEC-D, AMBIEN CR and ALEVE. On 13-MAR-2007, at approximately 19:00, the patient had a seizure while driving. The patient went to the emergency room and underwent unspecified blood tests and a computed axial tomography (results not reported). On 14-MAR-2007, the patient was too tired to go to work. The patient was advise to follow-up with a neurologist. It was recommended that the remainder of Gardasil series was held until neurologic work up was complete. Upon internal review, the patient's seizure was considered to be an other important medical event. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Neurological examination
Clinical narrative: Information has been received from a physician concerning a 24 year old white female with no pertinent medical history who on 13-MAR-2007, at 08:30, was vaccinated, into the right deltoid, with a first dose of GARDASIL (lot #657006/0188U). Concomitant therapy included ZYRTEC-D, AMBIEN CR and ALEVE. On 13-MAR-2007, at approximately 19:00, the patient had a seizure while driving. The patient went to the emergency room and underwent unspecified blood tests and a computed axial tomography (results not reported). On 14-MAR-2007, the patient was too tired to go to work. The patient was advise to follow-up with a neurologist. It was recommended that the remainder of Gardasil series was held until neurologic work up was complete. Upon internal review, the patient's seizure was considered to be an other important medical event. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Guillain-Barre syndrome
Clinical narrative: Information has been received from a nurse concerning a female (age not reported) who on an unspecified date was vaccinated with a dose of GARDASIL. Subsequently the patient developed Guillian-Barre syndrome. At the time of this report, the outcome was unknown. Upon internal review, Guillian-Barre syndrome was considered an other important medical event. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Convulsion
Clinical narrative: Information has been received from a nurse concerning a female (age not reported) who on an unspecified date was vaccinated with a dose of Gardasil. Subsequently the patient experienced "ongoing seizures". Upon internal review, the patient's seizures were considered an other important medical event. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Convulsion, Emergency care examination, Injection site irritation, Loss of consciousness
Clinical narrative: Information has been received from a certified nurses aid concerning a 19 year old female who on 22-MAR-2007 was vaccinated with the first dose of GARDASIL. Concomitant medication was reported as none. On 22-MAR-2007, the patient experienced burning feeling at the injection site, the patient passed out and had a seizure for about 10 minutes. An ambulance was called and the patient was rushed to the emergency room. The outcome and causality of the events were not reported. Burning feeling at the injection site, passed out and seizure were considered to be other important medical events. Additional information has been requested.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Attention deficit/hyperactivity disorder, Autism, Autism spectrum disorder, Blood lead, Communication disorder
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Metal poisoning, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Abnormal behaviour, Amino acid level normal, Ammonia normal, Attention deficit/hyperactivity disorder, Autism
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Autism spectrum disorder, Blood cholesterol normal, Cardiac murmur functional, Cognitive disorder, Communication disorder
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Conductive deafness, DNA test for fragile X, Deafness, Developmental delay, Eczema
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Full blood count, Impulse-control disorder, Laboratory test normal, Mental retardation severity unspecified, Metal poisoning
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Nervous system disorder, Neurodevelopmental disorder, Otitis media, Psychomotor skills impaired, Sneezing
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Social avoidant behaviour, Speech disorder, Speech disorder developmental, Thyroid function test normal, Unresponsive to stimuli
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Upper respiratory tract infection, Vitamin A normal
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Abnormal behaviour, Aphasia, Attention deficit/hyperactivity disorder, Autism, Autism spectrum disorder
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Cardiac murmur functional, Cognitive disorder, Communication disorder, Developmental delay, Expressive language disorder
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Hypokinesia, Impulse-control disorder, Learning disability, Mental impairment, Mental retardation severity unspecified
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Metal poisoning, Nervous system disorder, Neurodevelopmental disorder, Regressive behaviour, Social avoidant behaviour
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, DTP, HEP, HIBV, OPV, DTAP, IPV, MMR
Symptoms: Speech disorder, Speech disorder developmental, Stereotypy, Unresponsive to stimuli
Clinical narrative: This case was considered medically important. Information regarding Hib-Titer Vaccine was received from an attorney regarding a 4-year-old male patient who experienced autism spectrum disorder, autism, ADHD, neurological damage, neurodevelopmental disorder and mercury positioning. The patient received the fourth dose on 13-Aug-1997. The patient also received the first dose of Varivax and the fourth dose of DTP on 13-Aug-1997. On 13-Aug-1997, patient received a fourth dose of Hib vaccine along with other childhood immunizations. In February of 2000, at the age of 4, patient was diagnosed with severe communication disorder/autism spectrum disorder (autism spectrum disorder). On an unspecified dates, the patient was also diagnosed with mercury poisoning and neurological damage and neurodevelopmental disorder. In May of 2001 additional diagnoses of autism with an overlap of ADHD were then diagnosed as well. Blood lead (results: 4 ug/L was done on 23-Nov-1999. No additional was available at the time of this report.
Age: 57.0
Sex: F
Vaccine: TTOX
Symptoms: Hypoaesthesia, Nerve conduction studies, Nerve injury, Neurological examination, Oedema peripheral
Clinical narrative: SERIOUNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 22 March 2007 from the patient. A 57-year-old female with a medical history of allergy to "PCN", beta blockers, Seldane and "Anetime", and who had a cut on her leg from "furniture", had received a dose of TET TOX ADS USP, lot number 26388A, in the right arm on 18 October 2006. At an unspecified amount of time later, the patient's right hand was numb and her right hand and arm were swollen. She was seen in the emergency room and treated with Prednisone and antihistamines. The patient was evaluated by a surgeon and X-rays were sent to a neurologist. An ultrasound of the right arm and nerve conduction tests were completed. The results were not provided. Reportedly, there is "nerve damage". At the time of this report, the patient had not recovered.
Age: 57.0
Sex: F
Vaccine: TTOX
Symptoms: Ultrasound scan, X-ray
Clinical narrative: SERIOUNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT. Initial report received on 22 March 2007 from the patient. A 57-year-old female with a medical history of allergy to "PCN", beta blockers, Seldane and "Anetime", and who had a cut on her leg from "furniture", had received a dose of TET TOX ADS USP, lot number 26388A, in the right arm on 18 October 2006. At an unspecified amount of time later, the patient's right hand was numb and her right hand and arm were swollen. She was seen in the emergency room and treated with Prednisone and antihistamines. The patient was evaluated by a surgeon and X-rays were sent to a neurologist. An ultrasound of the right arm and nerve conduction tests were completed. The results were not provided. Reportedly, there is "nerve damage". At the time of this report, the patient had not recovered.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, HPV4, MNQ, HPV4, MNQ
Symptoms: Computerised tomogram abnormal, Fall, Head injury, Headache, Neck pain
Clinical narrative: Fainted within 10 min of receiving vaccines and fell backward and hit head on carpeted floor was unresponsive for 20-30 seconds. Complained of headache and neck pain. Transported to ER - CT showed traumatic subarachnoid hemorrhage. Transferred to PICU.  5/11/07 Received medical records from hospital which reveal patient experienced syncopal episode & fell backward w/o bracing herself, striking posterior head & becoming dazed & minimally responsive for several minutes.  Seen at outlying hospital & had CT scan which revealed SAH & skull fx.  Exam revealed alert & oriented, hematomas over skull.  Tx w/dilantin.  Neurosurg & neurology consults done.  Seizure was ruled out & dilantin d/c.  Strong suspicion for vascular abnormality due to amount of intracranial bleeding after fall. FINAL DX: traumatic subarachnoid hematoma.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, HPV4, MNQ, HPV4, MNQ
Symptoms: Subarachnoid haemorrhage, Syncope, Unresponsive to stimuli
Clinical narrative: Fainted within 10 min of receiving vaccines and fell backward and hit head on carpeted floor was unresponsive for 20-30 seconds. Complained of headache and neck pain. Transported to ER - CT showed traumatic subarachnoid hemorrhage. Transferred to PICU.  5/11/07 Received medical records from hospital which reveal patient experienced syncopal episode & fell backward w/o bracing herself, striking posterior head & becoming dazed & minimally responsive for several minutes.  Seen at outlying hospital & had CT scan which revealed SAH & skull fx.  Exam revealed alert & oriented, hematomas over skull.  Tx w/dilantin.  Neurosurg & neurology consults done.  Seizure was ruled out & dilantin d/c.  Strong suspicion for vascular abnormality due to amount of intracranial bleeding after fall. FINAL DX: traumatic subarachnoid hematoma.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, HPV4, MNQ, HPV4, MNQ
Symptoms: Dizziness, Fall, Head injury, Intensive care
Clinical narrative: Fainted within 10 min of receiving vaccines and fell backward and hit head on carpeted floor was unresponsive for 20-30 seconds. Complained of headache and neck pain. Transported to ER - CT showed traumatic subarachnoid hemorrhage. Transferred to PICU.  5/11/07 Received medical records from hospital which reveal patient experienced syncopal episode & fell backward w/o bracing herself, striking posterior head & becoming dazed & minimally responsive for several minutes.  Seen at outlying hospital & had CT scan which revealed SAH & skull fx.  Exam revealed alert & oriented, hematomas over skull.  Tx w/dilantin.  Neurosurg & neurology consults done.  Seizure was ruled out & dilantin d/c.  Strong suspicion for vascular abnormality due to amount of intracranial bleeding after fall. FINAL DX: traumatic subarachnoid hematoma.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, HPV4, MNQ, HPV4, MNQ
Symptoms: Dizziness, Fall, Head injury
Clinical narrative: Fainted within 10 min of receiving vaccines and fell backward and hit head on carpeted floor was unresponsive for 20-30 seconds. Complained of headache and neck pain. Transported to ER - CT showed traumatic subarachnoid hemorrhage. Transferred to PICU.  5/11/07 Received medical records from hospital which reveal patient experienced syncopal episode & fell backward w/o bracing herself, striking posterior head & becoming dazed & minimally responsive for several minutes.  Seen at outlying hospital & had CT scan which revealed SAH & skull fx.  Exam revealed alert & oriented, hematomas over skull.  Tx w/dilantin.  Neurosurg & neurology consults done.  Seizure was ruled out & dilantin d/c.  Strong suspicion for vascular abnormality due to amount of intracranial bleeding after fall. FINAL DX: traumatic subarachnoid hematoma.
Age: 45.0
Sex: F
Vaccine: PPV
Symptoms: Bronchial hyperreactivity, Coeliac disease, Eosinophilia myalgia syndrome, Erythema, Gastrooesophageal reflux disease
Clinical narrative: Bright red, swelling, hot to touch - that spread rapidly down my arm.  07/02/2007 MR received for a 3 night admit 3/30-4/2/2007 for cellulitis which had failed outpatient management.  Txd with IV and PO abx.  Final DX: RUE cellulitis at pneumovax site, failed outpt tx.  Chronic neutropenia. B12 deficiency.  iron deficiency.  RAD. GERD. Gluten entropathy. Eosinophilia-myalgia syndrome. multiple medication allergies
Age: 45.0
Sex: F
Vaccine: PPV
Symptoms: Injection site cellulitis, Iron deficiency, Neutropenia, Oedema peripheral, Skin warm
Clinical narrative: Bright red, swelling, hot to touch - that spread rapidly down my arm.  07/02/2007 MR received for a 3 night admit 3/30-4/2/2007 for cellulitis which had failed outpatient management.  Txd with IV and PO abx.  Final DX: RUE cellulitis at pneumovax site, failed outpt tx.  Chronic neutropenia. B12 deficiency.  iron deficiency.  RAD. GERD. Gluten entropathy. Eosinophilia-myalgia syndrome. multiple medication allergies
Age: 45.0
Sex: F
Vaccine: PPV
Symptoms: Vitamin B12 deficiency
Clinical narrative: Bright red, swelling, hot to touch - that spread rapidly down my arm.  07/02/2007 MR received for a 3 night admit 3/30-4/2/2007 for cellulitis which had failed outpatient management.  Txd with IV and PO abx.  Final DX: RUE cellulitis at pneumovax site, failed outpt tx.  Chronic neutropenia. B12 deficiency.  iron deficiency.  RAD. GERD. Gluten entropathy. Eosinophilia-myalgia syndrome. multiple medication allergies
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Acute respiratory distress syndrome, Blood pressure immeasurable, Heart rate normal, Loss of consciousness, Unresponsive to stimuli
Clinical narrative: Within 10 Minutes after receiving Varicella vaccine, pt vomited in car and passed out. Dad carried him back to office where he was unresponsive and incontinent of urine. Acute resp distress. No BP obtainable, pulse 60-70. Sent via ambulance to MC and admitted.  05/07/2007 MR received for o/n ER admission for an anaphylactic reaction  following his chicken pox vaccine.  As pt. was returning to his car he c/o stomach ache, vomitted, and immediately became unresponsive. EMS called and given O2 and epinephrine en route.  PE showed a diffuse maculopapular erythematous, non-pruritic rash, and a mildly tender abdomen upon palpation, otherwise WNL.  Txd with albuterol, solumedrol,and Zantac in the ED with improvement. D/C next day. Principal DX:  Anaphylaxis
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Urinary incontinence, Vomiting
Clinical narrative: Within 10 Minutes after receiving Varicella vaccine, pt vomited in car and passed out. Dad carried him back to office where he was unresponsive and incontinent of urine. Acute resp distress. No BP obtainable, pulse 60-70. Sent via ambulance to MC and admitted.  05/07/2007 MR received for o/n ER admission for an anaphylactic reaction  following his chicken pox vaccine.  As pt. was returning to his car he c/o stomach ache, vomitted, and immediately became unresponsive. EMS called and given O2 and epinephrine en route.  PE showed a diffuse maculopapular erythematous, non-pruritic rash, and a mildly tender abdomen upon palpation, otherwise WNL.  Txd with albuterol, solumedrol,and Zantac in the ED with improvement. D/C next day. Principal DX:  Anaphylaxis
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Immunisation reaction, Injection site erythema, Injection site swelling
Clinical narrative: swollen, redness 5 cm x 4 cm right arm, reaction to DTaP
Age: 22.0
Sex: M
Vaccine: TDAP
Symptoms: Chest pain, Fatigue, Headache, Injection site erythema, Injection site pain
Clinical narrative: 24 hours after injection experienced headache, chest pain, nausea, heart racing, fatigue, muscle aches, lasting about 24 hours. Also soreness at injection site lasting 5 days and redness. Heat to arm (Pt entered 4/4/07).
Age: 22.0
Sex: M
Vaccine: TDAP
Symptoms: Myalgia, Nausea, Palpitations
Clinical narrative: 24 hours after injection experienced headache, chest pain, nausea, heart racing, fatigue, muscle aches, lasting about 24 hours. Also soreness at injection site lasting 5 days and redness. Heat to arm (Pt entered 4/4/07).
Age: 19.0
Sex: M
Vaccine: TDAP
Symptoms: Diarrhoea, Nausea, Vomiting
Clinical narrative: nausea, persistent vomiting, diarrhea began a few hours after Tdap s/s x 4d not gradually resolved, not hospitalized.
Age: 65.0
Sex: U
Vaccine: VARZOS
Symptoms: Chest pain, Gallbladder disorder
Clinical narrative: Severe chest pains about 3 or 4 hrs of receiving shot of Zostavax. Diag as Gall Bladder problem. Required emerg. room treatment on 4/2/07 onset of pain after shot-2-4 hours.
Age: 16.0
Sex: F
Vaccine: IPV, MMR, TDAP
Symptoms: Body temperature increased, Eye pain, Headache
Clinical narrative: Client started experiencing eye pain 2/23/07 pm, a headache 2/24/07 and a temperature of 101.4. 2/26/07. Tc doctor-no further recommendations.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Rash
Clinical narrative: Severe rash L4-L5 dermatone RT after Zostavax with pain.  05/07/2007 MR received for several OVs from 03/19/2007 through 04/02/2007. Initial visit on 3/19/2007 for c/o Right leg pain which is getting worse. Pain is sharp and stabbing, comes in spasms.  PE shows tendeness to palpation of the Right lower quadriceps along the L4 distribution.  Patellar reflexes 3+/4+ bilaterally. Assessment: Radiculopathy.    F/u visit 3/26/2007 for ? Shingles. PE notes macular papular oozing rash on the Right lower extremity, buttocks, and inner thigh, front of shin. Assessment:  Herpes Zoster.
Sex: U
Vaccine: DTAP
Symptoms: Pyrexia, Wrong drug administered
Clinical narrative: A pharmacist reported that 80 employees received Daptacel vaccinations instead of Adacel when Adacel was incorrectly sent to the employee health department by pharmacy. No serious harm resulted but 5 employees reported a fever as a result of a mix-up in administration. Five employees reported a fever as a result of the mix-up in administration.
Age: 5.5
Sex: F
Vaccine: DTAP, IPV, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: shot site w/9cm x 12 1/2 cm area of warmth, redness, induration
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Injection site swelling, Injection site warmth, Pyrexia
Clinical narrative: Child developed hot, swollen left arm at site of injection along with 100 deg fever, and skin turned bright red all over body
Age: 27.0
Sex: M
Vaccine: TD
Symptoms: Chills, Headache, Influenza like illness, Pyrexia
Clinical narrative: Flu-like symptoms-fever and chills. Per patient, temp 101 for much of time from 3/29-4/01/07 fever down with IBU (took 1 ibuprofen 600 mg every 6 hr). On 4/02/07, felt only slight headache; On 4/03/07 no symptoms at all, no headache, no fever, no chills
Age: 0.19
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Injection site swelling
Clinical narrative: Left leg severely swollen several days after the shot.
Sex: F
Vaccine: MMR
Symptoms: Pyrexia
Clinical narrative: Fever 101, heart palpitation, onset approximately 90 minutes after receiving MMR.
Age: 15.0
Sex: M
Vaccine: HEP, IPV, MMRV, MNQ, TDAP
Symptoms: Unevaluable event
Clinical narrative: none
Age: 51.0
Sex: M
Vaccine: PPV, TDAP, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Laboratory test
Clinical narrative: Injection given in rt. deltoid on 04.04.2007. Pt returned to clinic on 04.06.2007 with c/o pain, redness and swollen. Pt stated pain started about 5hrs later. Pt advised to put Ice on the site and take ibuprofen, also pt had labs drawn.
Age: 51.0
Sex: M
Vaccine: PPV, TDAP, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Injection given in rt. deltoid on 04.04.2007. Pt returned to clinic on 04.06.2007 with c/o pain, redness and swollen. Pt stated pain started about 5hrs later. Pt advised to put Ice on the site and take ibuprofen, also pt had labs drawn.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Lip swelling, Rash, Throat irritation
Clinical narrative: Patient complained of itching in the throat, had swelling of the lips, redness of the face and rash/irritation under the right arm, approximately 45 minutes after recieving the varicella vaccine.  Patient was advised by triage nurse to give 1 1/2 tablets of chewable benadryl and bring patient immediatley to the ED.
Age: 64.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Headache, Herpes zoster, Rash vesicular
Clinical narrative: Patient had headache 2 days after injection lasting 8 days. Patient had vessicular rash left abdomen and reddened area left face within three days of injection. Patient was diagnosed with Zoster on 3/12/2007 and treated with Famvir.
Age: 64.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Headache, Herpes zoster, Rash
Clinical narrative: Patient had headache 2 days after injection lasting 8 days. Patient had vessicular rash left abdomen and reddened area left face within three days of injection. Patient was diagnosed with Zoster on 3/12/2007 and treated with Famvir.
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Abdominal pain, Diarrhoea, Headache, Lethargy, Nausea
Clinical narrative: lethargy,nausea,abdominal cramps,headache,body aches,emesis,diarrhea.
Age: 32.0
Sex: M
Vaccine: ANTH
Symptoms: Pain, Vomiting
Clinical narrative: lethargy,nausea,abdominal cramps,headache,body aches,emesis,diarrhea.
Age: 11.0
Sex: M
Vaccine: FLU3, HEPA, MNQ, TDAP, VARCEL
Symptoms: Urticaria
Clinical narrative: Pt returned to facility two days after his vaccinations with hives on both legs.  Mother stated it had started yesterday and was not spreading any more.  No difficulty in breathing.
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ, TTOX, HPV4, MNQ, TTOX, HPV4, MNQ, TTOX
Symptoms: Chromatopsia, Dyspnoea, Hypotension, Injection site pain, Oral pain
Clinical narrative: Within one minute following injections, patient experienced flashing lights in her eye; could only see in bright primary colors; had extreme trouble breathing; experienced pain in top of mouth and throat; pain at injection site; blood pressure was low. Symptoms started to subside after injection of Epinephrine and use of Nebulizer. She has no history of food or pollen allergies.
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ, TTOX, HPV4, MNQ, TTOX, HPV4, MNQ, TTOX
Symptoms: Pharyngolaryngeal pain, Photopsia
Clinical narrative: Within one minute following injections, patient experienced flashing lights in her eye; could only see in bright primary colors; had extreme trouble breathing; experienced pain in top of mouth and throat; pain at injection site; blood pressure was low. Symptoms started to subside after injection of Epinephrine and use of Nebulizer. She has no history of food or pollen allergies.
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ, TTOX, HPV4, MNQ, TTOX, HPV4, MNQ, TTOX
Symptoms: Hypotension, Paraesthesia oral, Throat irritation, Vision blurred
Clinical narrative: Within one minute following injections, patient experienced flashing lights in her eye; could only see in bright primary colors; had extreme trouble breathing; experienced pain in top of mouth and throat; pain at injection site; blood pressure was low. Symptoms started to subside after injection of Epinephrine and use of Nebulizer. She has no history of food or pollen allergies.
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ, TTOX, HPV4, MNQ, TTOX, HPV4, MNQ, TTOX
Symptoms: Hypotension, Paraesthesia, Paraesthesia oral, Vision blurred
Clinical narrative: Within one minute following injections, patient experienced flashing lights in her eye; could only see in bright primary colors; had extreme trouble breathing; experienced pain in top of mouth and throat; pain at injection site; blood pressure was low. Symptoms started to subside after injection of Epinephrine and use of Nebulizer. She has no history of food or pollen allergies.
Age: 1.47
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Audiogram abnormal, Deafness, Deafness neurosensory, Ear tube insertion, Induration
Clinical narrative: Had acute onset of fever, rash and joint swelling about 9 days after her MMR and varicella immunizations.  By review of chart records and discussion with the family, she appears to have had a "serum-sickness"-like reaction.  She was also on amoxicillin at the time of the illness.  After her hospitalization, she developed a sensorineural hearing loss which has persisted. 4/27/07 Received medical records from outpatient clinic From 6/04 thru 11/05 which reveal patient experienced delayed speech, hearing loss, frequent bouts of OM, frequent loose stools which responded well when changed to soy milk.  PE tubes were placed 12/04 but patient continued w/frequent bouts of OM.  Several audiology examination did reveal sensorineural hearing loss, w/abnormal tympanogram & speech delay.  Received Speech Tx. Fitted for hearing aids 5/05.  Speech improved w/treatments.  PE tubes had to be reinserted & had adenoidectomy at same time.   FINAL DX: Sensorineural hearing loss, delayed speech. 7/17/07 Received hospital medical records dated 6/19-6/21/2004. Admitted for diffuse erythematous indurated rash, bilateral knee & ankle swelling, facial puffiness, nasal discharge & fever.  No D/C summary available. FINAL DX: Fever, rash & joint swelling. 1/4/10 Bilateral Sensorineural hearing loss requiring hearing aids.
Age: 1.47
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Joint swelling, Pyrexia, Rash, Serum sickness
Clinical narrative: Had acute onset of fever, rash and joint swelling about 9 days after her MMR and varicella immunizations.  By review of chart records and discussion with the family, she appears to have had a "serum-sickness"-like reaction.  She was also on amoxicillin at the time of the illness.  After her hospitalization, she developed a sensorineural hearing loss which has persisted. 4/27/07 Received medical records from outpatient clinic From 6/04 thru 11/05 which reveal patient experienced delayed speech, hearing loss, frequent bouts of OM, frequent loose stools which responded well when changed to soy milk.  PE tubes were placed 12/04 but patient continued w/frequent bouts of OM.  Several audiology examination did reveal sensorineural hearing loss, w/abnormal tympanogram & speech delay.  Received Speech Tx. Fitted for hearing aids 5/05.  Speech improved w/treatments.  PE tubes had to be reinserted & had adenoidectomy at same time.   FINAL DX: Sensorineural hearing loss, delayed speech. 7/17/07 Received hospital medical records dated 6/19-6/21/2004. Admitted for diffuse erythematous indurated rash, bilateral knee & ankle swelling, facial puffiness, nasal discharge & fever.  No D/C summary available. FINAL DX: Fever, rash & joint swelling. 1/4/10 Bilateral Sensorineural hearing loss requiring hearing aids.